GlobeImmune Inc (GBIM)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
C. Jeffrey Dekker
Employees:
2
1450 INFINITE DRIVE, LOUISVILLE, CO 80027
3036252744

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

GlobeImmune, Inc. is a biopharmaceutical company, which focuses on developing therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke and Alex Franzusoff on February 10, 1995 and is headquartered in Louisville, CO.

Data derived from most recent annual or quarterly report
Market Cap 448.623 Thousand Shares Outstanding5.752 Million Avg 30-day Volume 35.496 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.36
Price to Revenue1.9349 Debt to Equity0.0 EBITDA-1.941 Million
Price to Book Value5.5906 Operating Margin-33.2963 Enterprise Value3.327 Million
Current Ratio2.28 EPS Growth-1.007 Quick Ratio2.097
1 Yr BETA 1.1442 52-week High/Low 0.0 / Profit Margin-33.2963
Operating Cash Flow Growth35.8283 Altman Z-Score-30.8944 Free Cash Flow to Firm -5.165 Million
View SEC Filings from GBIM instead.

View recent insider trading info

Funds Holding GBIM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GBIM

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2016-07-05:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-05-19:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2016-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-03-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-02-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-02-03:
    Item 8.01: Other Events
  • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    LAWLOR AUGUSTINE

    • Director
    463,267 2016-03-18 0

    TORRES S. EDWARD

    • Director
    241,706 2016-03-17 0

    MITCHELL DANIEL J

    • Director
    76,794 2016-03-16 0

    HEALTHCARE VENTURES VII LP

    CAVANAUGH JAMES H

    HEALTHCARE PARTNERS VII, L.P.

    LAWLOR AUGUSTINE

    LITTLECHILD JOHN W

    MIRABELLI CHRISTOPHER

    WERNER HAROLD R

    • Director
    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    No longer subject to file 2016-02-17 0

    CHRISTOFFERSEN KIRK A VP, CORPORATE DEVELOPMENT

    • Officer
    No longer subject to file 2015-08-03 0

    FREYTAG J WILLIAM

    • Director
    0 2015-07-09 0

    RODELL TIMOTHY C JR CEO & PRES

    • Officer
    • Director
    1,904 2015-04-10 0

    DEKKER C. JEFFREY VP, FINANCE, TREAS & SEC

    • Officer
    0 2015-01-06 0

    SAFER PENNINA

    • Director
    No longer subject to file 2014-09-30 0

    CELGENE INTERNATIONAL INC

    CELGENE CORP /DE/

    • 10% Owner
    600,670 2014-07-08 0

    MORGENTHALER PARTNERS VII LP

    MORGENTHALER MANAGEMENT PARTNERS VII, LLC

    • 10% Owner
    No longer subject to file 2014-07-08 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    GLOBEIMMUNE INC GBIM 2022-01-07 22:15:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 21:45:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 21:15:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 20:45:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 20:15:04 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 19:45:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 19:15:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 18:45:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 18:15:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 17:45:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 17:15:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 16:45:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 16:15:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 15:45:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 15:15:04 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 14:45:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 14:15:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 13:45:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 13:15:03 UTC -14.4373 14.5073 9000
    GLOBEIMMUNE INC GBIM 2022-01-07 12:45:03 UTC -14.4373 14.5073 9000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments